Patryk Mikucki
Chief Tech/Sci/R&D Officer bei ALEXION PHARMACEUTICALS, INC.
Profil
Patryk Mikucki is currently working as the Vice President of Clinical Research at Alexion Pharmaceuticals, Inc. and as the Vice President at Astrazeneca Pharma Poland SP zoo.
He is also a Member of the Supervisory Board at Scope Fluidics SA. Dr. Mikucki has an MBA from the University of Illinois and a doctorate from the University of Life Sciences in Lublin.
Aktive Positionen von Patryk Mikucki
| Unternehmen | Position | Beginn |
|---|---|---|
| SCOPE FLUIDICS S.A. | Director/Board Member | 29.06.2018 |
| ALEXION PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | - |
| Astrazeneca Pharma Poland SP zoo | Corporate Officer/Principal | - |
Ausbildung von Patryk Mikucki
| University of Illinois | Masters Business Admin |
| University of Life Sciences In Lublin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCOPE FLUIDICS S.A. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Alexion Pharmaceuticals, Inc.
 Alexion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Alexion Pharmaceuticals, Inc. engages in the business of serving patients and families affected by rare diseases and devastating conditions through the discovery, development, and commercialization of life-changing medicines. The firm also focuses on the development of haematology, nephrology, neurology, metabolic disorders, cardiology, and ophthalmology. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto, and Leonard Bell in January 1992 and is headquartered in Boston, MA. | Health Technology |
| Astrazeneca Pharma Poland SP zoo |
